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Edited by Horst FeldmannAbstract The 26S proteasome contains a proteolytic core, 20S
proteasome, and its regulatory particle, 19S complex. That
regulatory particle contains six ATPases that are involved in
unfolding and translocation of substrates to the 20S protea-
some’s catalytic chamber. We expressed ATPase-encoding genes
of the regulatory particle of Saccharomyces cerevisiae and
found that some recombinant ATPases can self-assemble into a
high-molecular-weight protein complex in Escherichia coli.
Puriﬁcation of the Rpt1Rpt2 hetero-complex and the Rpt4
homo-complex for functional characterization demonstrated
their contribution to energy-dependent protein degradation.
Our ﬁnding, production of a functional subunit of the 19S
regulatory particle in bacteria, is a simpler and technically
advanced system to functionally characterize individual subunits.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The 26S proteasome, which plays diverse roles in intra-cel-
lular proteolysis, is a highly conserved protease complex
among eukaryotes [1]. It comprises two major complexes:
catalytic 20S proteasome and 19S regulatory particles. The
20S proteasome is a multicatalytic protease complex that
sequesters catalytic centers in the inner space of the complex
[1,2]. The 19S regulatory particle binds one or both ends of the
20S proteasome and confers substrate selectivity; thereby, the
26S proteasome degrades ubiquitinated proteins. The 19S
regulatory particle is responsible for binding to the ubiquitin-
chain-tagged substrates, unfolding, translocation into the 20S
proteasome and refolding of the substrates [1,3]. The primary
components comprising the regulatory particle are the base
and the lid [4]. The base, which contains six ATPases and
two non-ATPases, is connected to the 20S proteasome. Six
ATPases belong to the AAA-ATPase family and they are
homologous to each other [5]. Most AAA-ATPases generally
form an oligomer and hydrolyze ATP at the interfaces of* Corresponding author. Fax: +81-11-857-8980.
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non-ATPases and is bound to the base [7].
Archaebacteria and eubacteria also have proteasomes that
are well conserved with the 20S proteasome of eukaryotes [8].
The proteasome acts with an ATPase complex and degrades
protein substrates in an ATP-dependent fashion. One example
is the S4 homolog from Methanococcus jannaschii, named
PAN, which forms a homo-oligomeric structure and acts as an
activator of the proteasome [9]. Bacterial energy-dependent
protein degradation systems are often associated with AAA-
ATPase complexes as well as proteasomes; ClpAP is composed
of a ClpP protease complex and an ATPase complex, ClpA.
ClpXP is composed of ClpP and another ATPase complex,
ClpX [10,11]. The HslUV system comprises a protease com-
plex, HslV, and an ATPase complex, HslU [12]. In eukaryotes,
the activator of the proteasome is more diﬀerentiated, but the
ancestor of yeast 26S proteasome could be simply the 20S
proteasome and an ATPase complex, like a bacterial and
archaeal system. It seems possible to re-construct a simpliﬁed
yeast proteolytic system in vitro using the 20S proteasome and
an ATPase homo-oligomeric complex.2. Materials and methods
2.1. Strains, plasmids, media and antibodies
We PCR-ampliﬁed RPT1, RPT2, RPT3, RPT4, RPT5, and RPT6
genes of Saccharomyces cerevisiae (W303 strain). Subsequently, each
DNA fragment was inserted into the NdeI/XhoI gap of pET28b
(Novagen Corp., Madison, WI) to yield N-terminally 6His-tagged
protein. A gene cassette containing T7 promoter, RPT1, and T7
terminator was inserted into the BglII site of 6His-RPT2-expression
vector to express RPT1 and 6His-RPT2 simultaneously. Dr. Ishii
(RIKEN) kindly provided a GroEL/S expression vector, pT-groE. We
purchased Anti-Rpt polyclonal antibodies (Aﬃniti Research Products,
Ltd., UK), anti-6His monoclonal antibody (Covance Inc., Richmond,
CA), and anti-GroEL polyclonal antibody (Sigma–Aldrich Corp., St.
Louis, MO). Alkaline phosphatase-conjugated secondary antibodies
were purchased from Promega Corp. (Madison, WI).
2.2. Expression and puriﬁcation of recombinant Rpt proteins
Recombinant proteins were expressed in E. coli BL21(DE3) carrying
pT-groE [13] and experimental plasmid(s). Genes were induced at
16 C for 20 h; then 6His-tagged proteins were isolated using Ni-NTA
superﬂow (Qiagen, GmbH, Germany) according to the manufacturer’s
instructions. To isolate Rpt4, the fractions containing Rpt4 proteins
were pooled and adjusted to the ﬁnal buﬀer concentration of 0.1 M
phosphate, 10% glycerol and 0.5 mM DTT and subjected to a hy-
droxyapatite (Bio-gel HTP; Bio-Rad Laboratories, Inc., Hercules, CA)blished by Elsevier B.V. All rights reserved.
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pH 7.0, 10% glycerol, and 0.5 mM DTT). After washing the column
with buﬀer A and buﬀer B (0.2 M potassium phosphate, pH 7.0, 10%
glycerol, and 0.5 mM DTT), Rpt4 was eluted with buﬀer C (0.5 M
potassium phosphate, pH 7.0, 10% glycerol, and 0.5 mM DTT). The
eluate was diluted immediately with buﬀer D (20 mM HEPES–NaOH,
pH 8.0, 10% glycerol, and 0.5 mM DTT) to 1/2, followed by addition
of Tween 20 to a ﬁnal concentration of 0.02%. After dialysis against
buﬀer D, the sample was concentrated and subjected to 10–40%
glycerol density gradient centrifugation (85; 000 g 22 h) prepared
with buﬀer E (20 mM HEPES–NaOH, pH 8.0, 0.5 mM DTT, 0.1 mM
ATP, 0.02% Tween 20 and glycerol). From a 10-l culture of E. coli
cells, 0.3 mg of Rpt4 was isolated. To isolate the Rpt1Rpt2 complexes,
glycerol density gradient centrifugation was performed before
hydroxyapatite chromatography. The Rpt1Rpt2 complex (133 lg) was
isolated from a 10-l culture of E. coli.Fig. 2. Characterization of Rpt4 and Rpt1Rpt2. (A) Native-PAGE
analysis of the Rpt4 complex. Puriﬁed Rpt4 protein (3.2 lg) and yeast
20S proteasome (1.2 lg) were subjected to a native-PAGE (4–20%
gradient of acrylamide) analysis. (B) Co-puriﬁcation of Rpt1 and
Rpt2. Extract from cells expressing 6His-RPT2 and untagged RPT1
was prepared and proteins from soluble fraction were batch-puriﬁed
using Ni-NTA (N: lanes 1 and 3). Insoluble materials were dissolved in
8 M urea, followed by puriﬁcation (D: lanes 2 and 4). Eluates were
analyzed by Western blotting (left, anti-Rpt1; right, anti-Rpt2). (C)
Co-sedimentation of Rpt1 and Rpt2. RPT1 and 6His-RPT2 were co-
expressed in E. coli cells and puriﬁed by Ni-NTA chromatography
followed by glycerol density gradient centrifugation. Fractions of the
gradient were subjected to Western blot analysis using anti-Rpt1 and
anti-Rpt2 antibodies. (D) Puriﬁcation of the Rpt1Rpt2 complex.
Fractions 14–19 of ﬁgure (C) (over 669 kDa) were pooled and sub-
jected to hydroxyapatite chromatography. Puriﬁed proteins were
subjected to SDS–PAGE and Western blot analyses using anti-Rpt1
and anti-Rpt2 antibodies. (E) Native-PAGE analysis of the Rpt1Rpt2
complex. The yeast 20S proteasome (2.0 lg) and the Rpt1Rpt2 com-
plex (2.9 lg) were analyzed by native-PAGE.3. Results and discussion
3.1. Expression of recombinant ATPases
RPT1, RPT2, RPT3, RPT4, RPT5, and RPT6 were ex-
pressed in the same E. coli cell to make an artiﬁcial complex of
Rpt ATPases. Recombinant proteins were puriﬁed using Ni-
NTA resin followed by fractionation using glycerol density
gradient centrifugation. Western blotting analyses of fractions
revealed that all ATPases sedimented only in low-density
fractions, although they were independently expressed (data
not shown). We accordingly expressed an individual ATPase.
Western blot analysis of the fractions from each glycerol
density gradient centrifugation revealed that sedimentation
proﬁles of respective ATPases are diﬀerent (Fig. 1). Rpt1, Rpt4
and Rpt5 were distributed in two peaks, in fractions 5–7 and
13–15. Rpt3 peaked in fractions 13–15. Rpt2 and Rpt6 were
detected only in low-density fractions. Rpt1, Rpt3, Rpt4 and
Rpt5 seemed to form oligomeric complexes independently,
compared to GroEL/S, which forms an approximately 900
kDa complex, peaked between fractions 13 and 17. Rpt4 was
the most suitable material for the substantial preparation. It
was used as a representative ATPase. On native-PAGE, the
migration proﬁle of Rpt4 was nearly identical to that of the
20S proteasome (Fig. 2A). These results indicate that Rpt4
assembles into a high molecular weight complex; Rpt4
sedimented in glycerol density gradient at the similar value ofFig. 1. Recombinant Rpt proteins form high-molecular-weight com-
plexes. Recombinant 6His-Rpt proteins were batch-puriﬁed individu-
ally and separated by glycerol density gradient centrifugation. The
fractions were subjected to Western blot analysis using anti-Rpt (to
detect Rpt1, Rpt2, Rpt3, and Rpt5) or anti-6His (to detect Rpt4 and
Rpt6) antibodies. Expressed genes in each experiment (left) and anti-
bodies used for Western blot analyses (right) are shown.GroEL (Fig. 1). Another representative material was Rpt2
because Rpt2 was well characterized by genetic studies [14,15].
Attempts to express RPT2 with a gene encoding other ATPase
components, Rpt3, Rpt4, Rpt5 and Rpt1, were performed
because Rpt2 could not self-assemble into a complex as stated
above. We found that Rpt2 was solubilized remarkably and
formed a complex only when it was co-expressed with RPT1.
As shown in Fig. 2C, both Rpt1 and Rpt2 were detected in
fractions 13 and 15 of the glycerol density gradient centrifu-
gation. Co-expression of 6His-RPT2 and untagged RPT1
showed that Rpt1 was detected in the eluate only when pro-
teins were isolated under a native condition, whereas 6His-
Rpt2 was eluted substantially from the Ni-NTA column under
both native and denaturing conditions (Fig. 2B). Co-puriﬁca-
tion of Rpt1 and Rpt2 was also conﬁrmed by a complementary
experiment, using cells co-expressing 6His-RPT1 and un-
tagged RPT2 (data not shown). Reportedly, S4, a mammalian
homolog of Rpt2, interacted with S7, a mammalian homolog
of Rpt1, in both biochemical experiment and a yeast two-
hybrid system [16,17], suggesting that Rpt2 is positioned next
to Rpt1 in the 19S regulatory particle. The puriﬁed complex
from high-density fractions of glycerol density gradient cen-
trifugation (Fig. 2C) contains two proteins that were con-
ﬁrmed to be identical to Rpt1 and 6His-Rpt2 by Western blot
analysis (Fig. 2D). The protein-staining proﬁle implies 1:1
stoichiometry of Rpt1 and Rpt2 in the complex, suggesting
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J. Takeuchi, T. Tamura / FEBS Letters 565 (2004) 39–42 41that Rpt1 and Rpt2 are incorporated alternately into a high-
molecular weight complex. On native-PAGE, the Rpt1Rpt2
complex migrated a little slower than the 20S proteasome did
(Fig. 2E). The Rpt1Rpt2 complex sedimented in glycerol
density gradient at the same fraction of Rpt4 complex. Both
Rpt1Rpt2 and Rpt4 complexes are of similar size as PAN,
which forms a dimerized ring structure of 650 kDa in size
[9,18]. Further puriﬁcation of the Rpt4 and Rpt1Rpt2 complex
was not successful because Rpt proteins are easily unstabilized
and aggregated. Precise determination of molecular size and
stoichiometry of the components in the complexes was not
accomplished. However, because AAA-ATPase is thought to
hydrolyze ATP at the interface between neighboring subunits
and the structure between adjacent subunits is critical [6], it can
be inferred that Rpt1Rpt2 and Rpt4 complexes have ring-
shaped structures as do other AAA-ATPases complexes, e.g.,
HslU and PAN [5,18].
3.2. Rpt oligomer exhibits ATP-hydrolyzing activity
The ATPase activities of the puriﬁed Rpt1Rpt2 complex and
Rpt4 complex were examined. Results indicated that the spe-
ciﬁc activities of Rpt1Rpt2 and Rpt4 were 0.88 and 0.13 lmol
Pi/h/mg, respectively. The exhibited ATPase activity of the
Rpt1Rpt2 complex was nearly the same level as that of the 19S
regulatory particle from mammalian cells [19]. When the re-
action mixture contained a-casein, which is known to be de-
graded by the proteasome, the ATPase activity of both
Rpt1Rpt2 and Rpt4 was not activated. However, when the
reaction mixture contained both of a-casein and the protea-
some from Thermoplasma, the ATPase activity of Rpt1Rpt2
complex was increased markedly (2.14 lmol Pi/h/mg) and that
of Rpt4 was increased slightly (Fig. 3). In contrast to a-casein,
the experiment used proteasome-resistant polypeptide ECFP
showed that the ATPase activity was not stimulated (data not
shown). These results suggested that the ATPase activity is
coupled with casein degradation. In contrast to the archaeal
proteasome, we found that Tween 20 in the buﬀer inhibited the
yeast proteasomal peptidase activity in a dose-dependent
manner (data not shown). The mode of inhibitory action by
Tween 20 is unknown, but we hypothesized that Tween 20 may
interfere with the entrance of the 20S proteasome because
0.05% of SDS restored the activity under Tween 20. Therefore,n
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Fig. 3. ATP-hydrolyzing activity of Rpt proteins. ATPase activities of
the Rpt1Rpt2 complex (A) and Rpt4 complex (B) were measured.
Rpt1Rpt2 (0.05 lg) or Rpt4 (0.6 lg) was incubated with 2 mM ATP
and 10 mM MgCl2 in 16 mM HEPES–NaOH, pH 8.0, at 37 C (di-
amonds) in the presence of 6 lg of a-casein (triangles) or 2.9 lg of
Thermoplasma proteasomes (boxes), or both of them (open circles).
The amount of released inorganic phosphate was determined by
measurement of absorption ðv640 nmÞ [20]. Experiments were repeated
three times and averages of those values were plotted.we used proteasome from Thermoplasma for characterization
of ATPase complex.
3.3. Rpt complexes activate protein degradation by the archaeal
proteasome
Although a-casein was slowly hydrolyzed by proteasomes
alone, the degradation-rate of a-casein increased when the
Rpt1Rpt2 complex was present in the reaction mixture
(Fig. 4A); in this experiment, the rate of degradation of a-casein
reﬂected the ATP-hydrolyzing activity (Figs. 3A and 4A).
When non-hydrolyzable ATP analog, ATP-cS, was used in-
stead of ATP, the Rpt1Rpt2 complex promoted the degrada-
tion of a-casein less eﬀectively than under the condition with
ATP. This result suggests that ATP binding to Rpt1Rpt2
stimulates proteolytic activity, although ATP hydrolysis
facilitates the protein degradation process.
When an Rpt4 complex was incubated with Thermoplasma
proteasome, the rate of a-casein degradation by the protea-
some also increased. Nevertheless, it was completely abolished
by addition of ATP-cS (Fig. 4B). These results indicate that
the activation of proteolysis by Rpt4 is entirely hydrolysis-
dependent. Results presented in Figs. 4A and B show that both
Rpt1Rpt2 and Rpt4 accelerated the degradation of a-casein at%
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Fig. 4. Breakdown of a-casein by the proteasome is accelerated by the
Rpt complex. (A) Rpt1Rpt2. a-Casein (10 lg) was incubated with 3.5
lg of Thermoplasma proteasome and 0.2 lg of Rpt1Rpt2 complex at
37 C in 80 ll of 15 mM HEPES–NaOH, pH 8.0, in the presence of 2
mM ATP and 5 mMMgCl2 (closed boxes). A 15-ll sample of reaction
mixture was collected every hour; the remaining a-casein was quanti-
ﬁed using a molecular imager (FX; Bio-Rad Laboratories, Inc.) after
SDS–PAGE analysis. Open boxes: ATP-cS was used instead of ATP.
Open triangles: the reaction mix was lacking Rpt1Rpt2. (B) Rpt4.
Experiments were performed as described in (A) except for use of Rpt4
instead of Rpt1Rpt2. Every circle corresponds to every box of exper-
iment A. (C) Comparison of initial rates of a-casein degradation by
diﬀerent amounts of Rpt1Rpt2 and Rpt4. a-Casein (10 lg) was incu-
bated with 3.5 lg of proteasome, 2 mM ATP, 5 mM MgCl2 and
various amounts of Rpt1Rpt2 complex (0–0.2 lg; closed boxes) or
Rpt4 (0–0.2 lg; closed circles). Total volume was adjusted to 80 ll with
buﬀer E of 20% glycerol and the mixture was incubated at 37 C. The
degraded casein was quantiﬁed as described in the legend for (A).
42 J. Takeuchi, T. Tamura / FEBS Letters 565 (2004) 39–42a two-times faster rate than that by the proteasome itself and
that a-casein degradation is the dose-dependent eﬀect of Rpt
(Fig. 4C). It is noteworthy that co-existence of Rpt1Rpt2 and
Rpt4 did not increase the rate of degradation of a-casein
co-operatively.
Overall, the proﬁle of proteasomal ATPase is similar to that
of PAN [21]. It has been reported that PAN from Methano-
coccus promotes the breakdown of casein by 20S proteasomes
from other sources, Thermoplasma acidophilum, Methanosar-
cina thermophila and rabbit muscle [9]. These observations
strongly suggest that primary sequences and domain organi-
zations are conserved between PAN and those of human and
yeast Rpt proteins, despite their very large evolutional
distance. The isolation of the complex of Rpts and proteasome
was not successful due to their weak interaction. Further
characterization of the mode of interaction of Rpts and
proteasome is required.
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